Ask AI
AD BBMs

CE / CME

Navigating Blood-Based Biomarkers for Alzheimer’s Disease: Current Clinical Utility and Research to Watch

Nurse Practitioners/Nurses: 0.25 Nursing contact hour, including 0.25 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Released: March 10, 2026

Expiration: March 09, 2027

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

We use blood-based biomarker (BBM) assays for Alzheimer’s disease (AD) in several clinical scenarios. If you saw patients for each of these scenarios, in which one would it NOT be appropriate to order BBM testing?